S2, 12 - Improve How You Move and More With Noninvasive Spinal Stimulation from SpineX

Cerebral palsy, spinal cord injury, and other neurological conditions can impact how information travels from your brain to other parts of your body. SpineX, a startup company in our 2023 Remarkable US Accelerator Program, develops noninvasive solutions that use painless electrical stimulation to change the nervous system’s activity to improve function and enhance quality of life. In this episode, you’ll hear more about the company and its innovative Spinal Cord Innovation in Pediatrics (SCiP™) device and Spinal Cord Neuromodulation (SCONE™) device from Kara Allanach, SpineX’s Director of Product. In the second part of our interview, you’ll meet Jessica, Van, and Annika Oldham. They discuss Annika’s cerebral palsy, their experiences with the SCiP™ device as part of two clinical research studies, and the improvements they’ve seen in Annika’s mobility. 

Please note: SCiP™ and SCONE™ are investigational devices and are limited by US federal law to investigational use only. The Food and Drug Administration has not yet reviewed the safety and effectiveness of SCIP™ or SCONE™. SpineX has not yet determined the most effective method of timing for therapy and is currently investigating these parameters in ongoing clinical trials.